Balance Labs, Inc.
BLNC
$2.11
-$0.05-2.32%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -5.66% | 4.65% | |||
| Gross Profit | 5.66% | -4.65% | |||
| SG&A Expenses | 10.92% | 75.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.63% | 23.13% | |||
| Operating Income | -0.63% | -23.13% | |||
| Income Before Tax | -2,182.81% | 94.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,182.81% | 94.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,182.81% | 94.56% | |||
| EBIT | -0.63% | -23.13% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -2,133.33% | 94.44% | |||
| Normalized Basic EPS | 0.00% | -11.43% | |||
| EPS Diluted | -3,233.33% | 94.44% | |||
| Normalized Diluted EPS | 0.00% | -11.43% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||